德国医药公司BioNTech(BNTX.US)股价今日盘中大涨5.58%,引发市场关注。
分析人士认为,这可能与新冠疫苗需求上升有关。从开发和销售新冠疫苗Comirnaty后,BNTX在疫苗领域建立了领先地位。随着不同国家疫情反复,特别是进入流行季节,各国对新冠疫苗都有较大需求,作为疫苗供应商的BNTX或将从中获益。
作为一家生物科技公司,BNTX拥有丰富的肿瘤疗法和传染病疫苗产品线,已与包括罗氏、礼来、辉瑞等多家制药巨头建立合作关系。在个体化免疫疗法、mRNA疫苗等前沿领域具有良好的技术储备和产品管线。生物技术行业也是当前科技前沿,预计未来将是一片广阔的增长蓝海。因此,市场对BNTX的长期前景持乐观态度。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.